VHL and nonpapillary renal cell carcinoma: We have shown previously that β2-blockers selectively decrease cell viability and induce apoptosis in VHL-CNS-HBs and VHL-ccRCC primary cells, as well as in the VHL-negative RCC 786-O cell line [2,12,14].